Stock Trading Canary

Built: 2026-10-19T16:02:49+00:00 · 中文

← South Korea

SOUTH KOREA · OPENDART

Genome&Company

지놈앤컴퍼니 · 314130 · KOSDAQ · Healthcare · Biotechnology

Score

Not ranked: no net buying on the exchange by an individual insider in the last 180 days.

Insider trades on the exchange

Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.

Trade dateInsiderRoleTradeSharesPriceValueFiling
2026-03-25Yu, HyunkyungManaging directorSold on the exchange6,000₩10,000₩60.0MDART ↗
2026-03-24SEO JIN KYEONGManaging directorSold on the exchange10,000₩9,455₩94.5MDART ↗
Other changes in holdings · 11

Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.

DateInsiderRoleReasonSharesFiling
2026-05-21Cha, Mi YoungVice presidentReceipt of donation(+)20,000DART ↗
2026-05-21Park HansooCEODonation(-)20,000DART ↗
2026-04-23SEO JIN KYEONGManaging directorExercise of appraisal rights(+)26,000DART ↗
2025-04-30Yu, HyunkyungManaging directorReceipt of donation(+)20,000DART ↗
2025-04-30SEO JIN KYEONGManaging directorReceipt of donation(+)10,000DART ↗
2025-04-30Cha, Mi YoungSenior managing directorReceipt of donation(+)20,000DART ↗
2025-04-30Park, Byoung kyuManaging directorReceipt of donation(+)50,000DART ↗
2025-04-30Kim SangkyunManaging directorReceipt of donation(+)40,000DART ↗
2025-04-30Pae JisooCEODonation(-)90,000DART ↗
2025-04-30Park HansooCEODonation(-)100,000DART ↗
2024-12-06Cha, Mi YoungSenior managing directorOthers(+)12,000DART ↗